Blue Trust Inc. Acquires Shares of 11,016 Healthpeak Properties, Inc. (NYSE:DOC)

Blue Trust Inc. purchased a new stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) during the third quarter, Holdings Channel.com reports. The fund purchased 11,016 shares of the real estate investment trust’s stock, valued at approximately $252,000.

A number of other large investors also recently made changes to their positions in the company. Douglas Lane & Associates LLC bought a new position in shares of Healthpeak Properties during the third quarter valued at about $33,947,000. Presima Securities ULC bought a new position in shares of Healthpeak Properties during the third quarter valued at about $22,465,000. AMF Tjanstepension AB bought a new position in shares of Healthpeak Properties during the third quarter valued at about $15,548,000. Handelsbanken Fonder AB bought a new stake in Healthpeak Properties in the third quarter worth about $11,668,000. Finally, Brookstone Capital Management bought a new stake in Healthpeak Properties in the third quarter worth about $11,018,000. 93.57% of the stock is owned by institutional investors.

Healthpeak Properties Price Performance

Shares of NYSE:DOC opened at $22.99 on Friday. The company has a 50 day moving average of $22.24 and a 200 day moving average of $20.64. The stock has a market cap of $16.18 billion, a P/E ratio of 65.69, a P/E/G ratio of 2.27 and a beta of 1.14. Healthpeak Properties, Inc. has a 12 month low of $15.24 and a 12 month high of $23.26. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.91.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Thursday, July 25th. The real estate investment trust reported $0.21 EPS for the quarter, missing the consensus estimate of $0.44 by ($0.23). The firm had revenue of $695.50 million for the quarter, compared to analysts’ expectations of $665.11 million. Healthpeak Properties had a net margin of 11.93% and a return on equity of 3.51%. Healthpeak Properties’s revenue was up 27.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.45 EPS. As a group, sell-side analysts forecast that Healthpeak Properties, Inc. will post 1.8 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have commented on DOC shares. Wells Fargo & Company reaffirmed an “equal weight” rating and issued a $23.00 price objective (up previously from $22.00) on shares of Healthpeak Properties in a research report on Tuesday, October 1st. Wedbush lifted their price objective on shares of Healthpeak Properties from $22.00 to $25.00 and gave the stock an “outperform” rating in a research report on Monday, July 29th. Evercore ISI lifted their price objective on shares of Healthpeak Properties from $25.00 to $26.00 and gave the stock an “outperform” rating in a research report on Monday, September 16th. Royal Bank of Canada lifted their price objective on shares of Healthpeak Properties from $22.00 to $25.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 30th. Finally, Scotiabank lifted their price objective on shares of Healthpeak Properties from $23.00 to $24.00 and gave the stock a “sector outperform” rating in a research report on Monday, September 9th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $22.62.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.